Nuvo Research is a specialty pharmaceutical company focused on improving patient’s lives by developing and commercializing innovative
Business Model:
Revenue: $9.1M
Employees: 11-50
Address: 6733
City: Mississauga
State: ontario
Zip: L5N 6J5
Country: CA
Nuvo Research is a specialty pharmaceutical company focused on improving patient’s lives by developing and commercializing innovative products that address unmet medical needs. The Company has a diverse portfolio of topical products and technologies and immunology products and a platform. Nuvo’s marketed products in the area of topical pain include: Pennsaid®, Pennsaid 2%, Pliaglis and the heated lidocaine/tetracaine patch. In the area of immunology the products include: Immunokine and Oxoferin
Contact Phone:
+19056736980
Contact Email:
Listed Exchange:
TMX Group - Toronto Stock Exchange
IPO Date:
11/4/2005
Ticker Symbol:
NRI
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2017 | Post-IPO Debt | 1 | $6M |
Royal Bank of Canada Royal Bank of Canada |
4/2014 | Post-IPO Equity | $3.1M |
---|
Announced Date | Name | Price |
---|---|---|
12/2018 | Aralez Pharmaceuticals | |
8/2018 | Tribute Pharmaceuticals Canada |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|